Key facts
- Notable investors include Leaguer Financial, Tisiwi, ZJKF Capital Management.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Nuka Smart
- ·The full record, as it builds
Funding rounds
No funding rounds for Nuka Smart are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nuka Smart
Developer of an AI-based protease development platform based on the interdisciplinary science of artificial intelligence and synthetic biology. The company focuses on the application of biological enzymes and gene editing tools through the combination of artificial intelligence and bioinformatics computing, which can greatly shorten the process of discovery and improvement of biological enzymes, reducing experimental costs, improving experimental efficiency, and bringing new productivity to the biotechnology industry.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Nuka Smart doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nuka Smart shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nuka Smart in its N-PORT filings yet. We sweep new filings monthly.